Dare Bioscience (DARE)
0.69
0.00 (0.00%)
Upcoming Events
Latest Headlines
Daré Bioscience Sponsors HERmedicine Educational Program for Clinicians on Managing Menopause After Breast Cancer
October 19, 2026 8:56 AM - StreetInsider
Daré Bioscience Launches “CEO Corner” Video Series to Highlight the Company’s Pipeline of Women’s Health Innovations, Corporate Strategy and Opportunities
October 13, 2026 9:15 AM - StreetInsider
Daré Bioscience to present sildenafil cream Phase 1 data at SMSNA
October 8, 2026 9:15 AM - StreetInsider
Daré Bioscience to Present Phase 1 Sildenafil Cream Data at Sexual Medicine Society of North America (SMSNA) Annual Fall Scientific Meeting
October 8, 2026 9:15 AM - StreetInsider
Form DEF 14A Dare Bioscience, Inc. For: Oct 06
October 6, 2026 5:00 PM - SEC Filing
Form 8-K Dare Bioscience, Inc. For: Sep 28
October 2, 2026 4:02 PM - SEC Filing
Form 8-K Dare Bioscience, Inc. For: Oct 01
October 1, 2026 9:01 AM - SEC Filing
Dare Bioscience stock rises after receiving HPV treatment patent
September 28, 2026 10:12 AM - StreetInsider
Daré Bioscience receives new U.S. patent for HPV treatment program
September 28, 2026 8:25 AM - StreetInsider
Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection
September 28, 2026 8:20 AM - StreetInsider
Form PRE 14A Dare Bioscience, Inc. For: Sep 23
September 23, 2026 4:05 PM - SEC Filing
Daré Bioscience publishes Phase 1 sildenafil cream data in men
September 14, 2026 8:50 AM - StreetInsider
Daré Bioscience Announces Peer-Reviewed Publication of Phase 1 Sildenafil Cream Study in Men Demonstrating Substantially Lower Systemic Exposure Versus Oral Sildenafil
September 14, 2026 8:50 AM - StreetInsider
Form 8-K Dare Bioscience, Inc. For: Sep 10
September 11, 2026 4:30 PM - SEC Filing
Daré Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-Demand
September 11, 2026 6:55 AM - StreetInsider
Daré Bioscience gets $908K NIH grant for preterm birth program
August 31, 2026 8:44 AM - StreetInsider
Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth
August 31, 2026 8:44 AM - StreetInsider
Form SCHEDULE 13G Dare Bioscience, Inc. Filed by: Lind Global Fund III LP
August 28, 2026 4:01 PM - SEC Filing
Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor “Why Now” On-Demand Series
August 27, 2026 9:01 AM - StreetInsider
Form S-1 Dare Bioscience, Inc.
August 26, 2026 5:16 PM - SEC Filing
Daré Bioscience publishes sildenafil cream Phase 1 data in menopause journal
August 26, 2026 8:45 AM - StreetInsider
Daré Bioscience’s Sildenafil Cream Data in Postmenopausal Women Published in Menopause - The Journal of The Menopause Society
August 26, 2026 8:45 AM - StreetInsider
Daré Bioscience CEO discusses pipeline and commercial shift
August 25, 2026 8:55 AM - StreetInsider
Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment
August 25, 2026 8:55 AM - StreetInsider
Form SCHEDULE 13G Dare Bioscience, Inc. Filed by: L1 Capital Global Opportunities Master Fund, Ltd.
August 24, 2026 4:10 PM - SEC Filing
Form D Dare Bioscience, Inc.
August 20, 2026 6:03 AM - SEC Filing
Form 253G2 Dare Bioscience, Inc.
August 19, 2026 4:59 PM - SEC Filing
DARÉ Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 “50 Over 50: Innovation” List
August 18, 2026 9:02 AM - StreetInsider
Form 8-K Dare Bioscience, Inc. For: Aug 14
August 17, 2026 8:36 AM - SEC Filing
Form 424B5 Dare Bioscience, Inc.
August 17, 2026 8:30 AM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Dare Bioscience (DARE)
August 17, 2026 6:50 AM - StreetInsider
Daré Bioscience prices $6M direct offering at $1.37 per share
August 14, 2026 12:45 PM - StreetInsider
Daré Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
August 14, 2026 12:45 PM - StreetInsider
Dare Bioscience (DARE) Tops Q2 EPS by 11c
August 14, 2026 1:50 AM - StreetInsider
Form 10-Q Dare Bioscience, Inc. For: Jun 30
August 13, 2026 4:03 PM - SEC Filing
Form 8-K Dare Bioscience, Inc. For: Aug 13
August 13, 2026 4:03 PM - SEC Filing
Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances
August 13, 2026 4:01 PM - StreetInsider
Daré Bioscience to Host Second Quarter 2026 Financial Results and Company Update Conference Call and Webcast on August 13, 2026
August 6, 2026 9:05 AM - StreetInsider
Daré Bioscience partners with MyMenopauseRx for telehealth access
July 28, 2026 8:34 AM - StreetInsider
Daré Bioscience Expands Access Options for DARE to PLAY™ and Specialized Menopause Care Through Strategic Collaboration with MyMenopauseRx
July 28, 2026 8:34 AM - StreetInsider
Form 8-K Dare Bioscience, Inc. For: Jul 24
July 24, 2026 9:01 AM - SEC Filing
Full Article List
